This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Roche Palo Alto LLC, Syntex (u.s.a.) Inc.. Active years: 2004-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2011
Title: The Inventor Spotlight: Wen Rong Jiang
Introduction
Wen Rong Jiang, a prolific inventor based in Redwood City, CA, has made significant contributions to the field of pharmaceuticals with his innovative patented inventions.
Latest Patents
With a total of four patents to his name, Jiang's latest inventions revolve around the development of 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication. These compounds have shown promising results in treating patients with HCV infections.
Career Highlights
Jiang has lent his expertise to renowned companies such as Roche Palo Alto LLC and Syntex (USA) Inc., where he has played a vital role in research and development efforts. His groundbreaking work has paved the way for advancements in antiviral therapies.
Collaborations
Throughout his career, Jiang has collaborated closely with esteemed colleagues such as Rene Robert Devos and Christopher John Hobbs. Together, they have worked tirelessly to push the boundaries of pharmaceutical innovation and improve patient outcomes.
Conclusion
In conclusion, Wen Rong Jiang's dedication to innovation and his remarkable contributions to the field of pharmaceuticals underscore his status as a visionary inventor. His patented inventions stand as a testament to his commitment to advancing medical science and improving the lives of individuals affected by HCV infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile